Tauopathy
Updates to Article Attributes
Tauopathies are a heterogeneous group of neurodegenerative diseases characterised by abnormal metabolism of tau proteins leading to intracellular accumulation and formation of neurofibrillary tangles (NFT). These neurofibrillary tangles are deposited in the cytosol of neurons and glial cells.
Examples of tauopathies include 3:
- Alzheimer disease
- progressive supranuclear palsy (PSP)
- frontotemporal lobar degeneration (FTLD)
- corticobasal degeneration
It should be noted that some texts 2 define tauopathies as a disease characterised by mutations in the tau protein gene itself. If such a strict definition is used, even though the histopathological hallmark ofAlzheimer disease disease is the presence of numerous neurofibrillary tangles (also(which is also formed by tau proteins) as, it still would not be strictly a tauopathy, as no defect in the tau protein gene has been identified it would not strictly be a tauopathy.
More recently the discovery of the glymphatic pathway and the importance of this in the normal physiological clearance of extracellular solutes including beta-amyloid, suggests that there is also the possibility of reduced clearance, in addition to abnormal metabolism, as the underpinning of some tauopathies including chronic traumatic encephalopathy 4.
-<li><a href="/articles/fronto-temporal-lobar-degeneration">frontotemporal lobar degeneration (FTLD)</a></li>- +<li><a href="/articles/frontotemporal-lobar-degeneration-1">frontotemporal lobar degeneration (FTLD)</a></li>
-</ul><p>It should be noted that some texts <sup>2</sup> define tauopathies as disease characterised by mutations in the tau protein gene itself. If such a strict definition is used, even though the histopathological hallmark of <a href="/articles/alzheimer-disease-1">Alzheimer disease</a> is the presence of numerous neurofibrillary tangles (also formed by tau proteins) as no defect in the tau protein gene has been identified it would not strictly be a tauopathy. </p><p>More recently the discovery of the <a href="/articles/glymphatic-pathway">glymphatic pathway</a> and the importance of this in the normal physiological clearance of extracellular solutes including beta-amyloid, suggests that there is also the possibility of reduced clearance, in addition to abnormal metabolism, as the underpinning of some tauopathies including <a href="/articles/chronic-traumatic-encephalopathy">chronic traumatic encephalopathy</a> <sup>4</sup>. </p>- +</ul><p>It should be noted that some texts <sup>2</sup> define tauopathies as a disease characterised by mutations in the tau protein gene itself. If such a strict definition is used, even though the histopathological hallmark of <a href="/articles/alzheimer-disease-1">Alzheimer disease</a> is the presence of numerous neurofibrillary tangles (which is also formed by tau proteins), it still would not be strictly a tauopathy, as no defect in the tau protein gene has been identified.</p><p>More recently the discovery of the <a href="/articles/glymphatic-pathway">glymphatic pathway</a> and the importance of this in the normal physiological clearance of extracellular solutes including beta-amyloid, suggests that there is also the possibility of reduced clearance, in addition to abnormal metabolism, as the underpinning of some tauopathies including <a href="/articles/chronic-traumatic-encephalopathy">chronic traumatic encephalopathy</a> <sup>4</sup>. </p>
Unable to process the form. Check for errors and try again.